Integrative clinical and molecular characterization of translocation renal cell carcinoma is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 118 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F31 CA250136
Dana-Farber/Harvard Cancer Center
Grant: P50-CA101942
National Cancer Institute
Grant: P50CA101942-15
Doris Duke Charitable Foundation
Grant: W81XWH-19-1-0815
NCI NIH HHS
Grant: P50 CA101942
Doris Duke Charitable Foundation
Grant: 2020101
NCI NIH HHS
Grant: T32 CA009172
National Institutes of Health
Grant: 1F31CA250136-01
Unraveling the influence of genetic subtype on spatial configurations of tissue and immune compartment composition in clear cell renal cell carcinoma
National Institutes of Health
Grant: 2P50CA101942-11A1
DF/HCC Kidney Cancer SPORE
Damon Runyon Cancer Research Foundation
EMD Serono
Eisai
Exelixis
Ipsen Biopharmaceuticals
National Cancer Center
Pfizer
Astellas Pharma US
Bristol-Myers Squibb
Genentech
Harvard Medical School
GlaxoSmithKline
American Association for Cancer Research
AstraZeneca
Bayer Fund
Rally Foundation
Roche
Janssen Pharmaceuticals
Takeda Pharmaceuticals U.S.A.
Conquer Cancer Foundation
Merck
Novartis
FWCI
14.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals